Use of Molecular Markers for Cytologically Indeterminate Thyroid Nodules to Optimize Surgical Management

被引:0
|
作者
Yip, Linwah [1 ]
机构
[1] Univ Pittsburgh, Dept Surg, Div Endocrine Surg & Surg Oncol, Suite 101,3471 Fifth Ave, Pittsburgh, PA 15213 USA
来源
CURRENT SURGERY REPORTS | 2014年 / 2卷 / 01期
关键词
Thyroid nodule; Thyroid cancer; Thyroidectomy; Molecular markers; Mutation testing; Indeterminate biopsy; Surgical management; MicroRNA; Rearrangements;
D O I
10.1007/s40137-013-0035-9
中图分类号
R61 [外科手术学];
学科分类号
摘要
The management of thyroid nodules with indeterminate cytology has traditionally been diagnostic thyroidectomy. However most nodules are benign, and for nodules that demonstrate histologic malignancy, two-stage thyroidectomy may be necessary. Molecular markers have emerged as an adjunct to preoperative FNAB cytology evaluation that can improve diagnostic accuracy. In this review, we discuss the latest methodologies and review diagnostic performance parameters of recent molecular marker techniques.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Use of Molecular Markers for Cytologically Indeterminate Thyroid Nodules to Optimize Surgical Management
    Linwah Yip
    Current Surgery Reports, 2 (1)
  • [2] Surgical management of cytologically indeterminate thyroid nodules
    Almquist, Martin
    Muth, Andreas
    GLAND SURGERY, 2019, 8 : S105 - S111
  • [3] Molecular markers for the classification of cytologically indeterminate thyroid nodules
    Muzza, M.
    Colombo, C.
    Pogliaghi, G.
    Karapanou, O.
    Fugazzola, L.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2020, 43 (06) : 703 - 716
  • [4] Molecular markers for the classification of cytologically indeterminate thyroid nodules
    M. Muzza
    C. Colombo
    G. Pogliaghi
    O. Karapanou
    L. Fugazzola
    Journal of Endocrinological Investigation, 2020, 43 : 703 - 716
  • [5] An update on management of cytologically indeterminate thyroid nodules
    Roy, Malanie
    Ghander, Cecile
    Bigorgne, Claude
    Briere, Mathilde
    Deniziaut, Gabrielle
    Ansart, Francois
    Lussey-Lepoutre, Charlotte
    Buffet, Camille
    ANNALES D ENDOCRINOLOGIE, 2025, 86 (02)
  • [6] Update on Molecular Testing for Cytologically Indeterminate Thyroid Nodules
    Bose, Shikha
    Sacks, Wendy
    Walts, Ann E.
    ADVANCES IN ANATOMIC PATHOLOGY, 2019, 26 (02) : 114 - 123
  • [7] OVERVIEW OF MOLECULAR BIOMARKERS FOR ENHANCING THE MANAGEMENT OF CYTOLOGICALLY INDETERMINATE THYROID NODULES AND THYROID CANCER
    Duick, Daniel S.
    ENDOCRINE PRACTICE, 2012, 18 (04) : 611 - 615
  • [8] Impact of oncogene panel results on surgical management of cytologically indeterminate thyroid nodules
    Valderrabano, Pablo
    Khazai, Laila
    Thompson, Zachary J.
    Leon, Marino E.
    Otto, Kristen J.
    Hallanger-Johnson, Julie E.
    Wadsworth, J. Trad
    Chung, Christine H.
    Centeno, Barbara A.
    McIver, Bryan
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2018, 40 (08): : 1812 - 1823
  • [9] Update on Molecular Testing for Cytologically Indeterminate Thyroid Nodules
    Nishino, Michiya
    Nikiforova, Marina
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2018, 142 (04) : 446 - 457
  • [10] Paired Comparison of Molecular Tests for Cytologically Indeterminate Thyroid Nodules
    Xia, Rong
    Zhou, Fang
    Sun, Wei
    Liu, Cheng
    Simsir, Aylin
    Cangiarella, Joan
    Brandler, Tamar
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 1180 - 1181